RE:InterestingI believe QPT has said they are willing to go to court to protect thier 45% interest in oregovomab. At best they end up getting Carariabio bonds and shares as payment for theier interest in oregovomab and the company does well. At worst the company goes to court to protect thier interest and wins and gets either cash and/or canariabio bonds and shares as payment for their interest in oregovomab and the company does well.
Both situations are a win for the company.
That's my take. I just bought another 5k shares.